⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALXO News
ALX Oncology Holdings Inc. Common Stock
ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026
globenewswire.com
ALXO
JAZZ
Gastroesophageal Adenocarcinoma Market Research Report 2026, Competitive Analysis of ALX Oncology, Merck, AstraZeneca, BeOne Medicines, Taiho Pharmaceuticals, Eli Lilly - Global Forecast to 2035
globenewswire.com
ALXO
MRK
AZN
LLY
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
globenewswire.com
ALXO
Form 8-K
sec.gov
ALXO
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
globenewswire.com
ALXO
Form 8-K
sec.gov
ALXO
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
ALXO
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
globenewswire.com
ALXO
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
globenewswire.com
ALXO
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME